Paul R. Fonteyne does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., resTORbio, Inc., COVETRUS, INC., Apellis Pharmaceuticals, Inc., GELESIS HOLDINGS, INC., and AMAG PHARMACEUTICALS, INC..

2022 was Paul R. Fonteyne's most active year for acquiring shares with 8 total transactions. Paul R. Fonteyne's most active month to acquire stocks was the month of December. 2026 was Paul R. Fonteyne's most active year for disposing of shares, totalling 13 transactions. Paul R. Fonteyne's most active month to dispose stocks was the month of April. 2024 saw Paul R. Fonteyne paying a total of $344,075.28 for 34,089 shares, this is the most they've acquired in one year. In 2026 Paul R. Fonteyne cashed out on 167,580 shares for a total of $0.00, their largest year based on trade value.